-
1
-
-
0034076189
-
Mechanisms of angiogenesis and arteriogenesis
-
Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nature Med 6 (2000) 389-395
-
(2000)
Nature Med
, vol.6
, pp. 389-395
-
-
Carmeliet, P.1
-
2
-
-
0024801035
-
Vascular permeability factor, an endothelial cell mitogen related to PDGF
-
Keck P.J., Hauser S.D., Krivi G., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 (1989) 1309-1312
-
(1989)
Science
, vol.246
, pp. 1309-1312
-
-
Keck, P.J.1
Hauser, S.D.2
Krivi, G.3
-
3
-
-
34247174730
-
The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy
-
Peyromaure M., Camparo P., Badoual C., Descazeaud A., and Dinh-Xuan A.T. The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy. BJU Int 99 (2007) 1150-1153
-
(2007)
BJU Int
, vol.99
, pp. 1150-1153
-
-
Peyromaure, M.1
Camparo, P.2
Badoual, C.3
Descazeaud, A.4
Dinh-Xuan, A.T.5
-
4
-
-
33845606748
-
Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome
-
Green M.M., Hiley C.T., Shanks J.H., et al. Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. Int J Radiat Oncol Biol Phys 67 (2007) 84-90
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.67
, pp. 84-90
-
-
Green, M.M.1
Hiley, C.T.2
Shanks, J.H.3
-
5
-
-
0035884219
-
Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results
-
Kerbel R.S. Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results. J Clin Oncol 19 (2001) 25
-
(2001)
J Clin Oncol
, vol.19
, pp. 25
-
-
Kerbel, R.S.1
-
6
-
-
2542421792
-
A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer
-
Stadler W.M., Cao D., Vogelzang N.J., et al. A randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clin Cancer Res 10 (2004) 3365-3370
-
(2004)
Clin Cancer Res
, vol.10
, pp. 3365-3370
-
-
Stadler, W.M.1
Cao, D.2
Vogelzang, N.J.3
-
7
-
-
0037096738
-
Influence of cytokine gene polymorphisms on the development of prostate cancer
-
McCarron S.L., Edwards S., Evans P.R., et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 62 (2002) 3369-3372
-
(2002)
Cancer Res
, vol.62
, pp. 3369-3372
-
-
McCarron, S.L.1
Edwards, S.2
Evans, P.R.3
-
8
-
-
0041621886
-
Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer
-
Lin C.C., Wu H.C., Tsai F.J., Chen H.Y., and Chen W.C. Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. Urology 62 (2003) 374-377
-
(2003)
Urology
, vol.62
, pp. 374-377
-
-
Lin, C.C.1
Wu, H.C.2
Tsai, F.J.3
Chen, H.Y.4
Chen, W.C.5
-
9
-
-
33749267776
-
Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome
-
Sfar S., Hassen E., Saad H., Mosbah F., and Chouchane L. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine 35 (2006) 21-28
-
(2006)
Cytokine
, vol.35
, pp. 21-28
-
-
Sfar, S.1
Hassen, E.2
Saad, H.3
Mosbah, F.4
Chouchane, L.5
-
10
-
-
38349183079
-
No association between polymorphism in the vascular endothelial growth factor gene at position-460 and sporadic prostate cancer in the Turkish population
-
Onen I.H., Konac E., Eroglu M., Guneri C., Biri H., and Ekmekci A. No association between polymorphism in the vascular endothelial growth factor gene at position-460 and sporadic prostate cancer in the Turkish population. Mol Biol Rep 35 (2008) 17-22
-
(2008)
Mol Biol Rep
, vol.35
, pp. 17-22
-
-
Onen, I.H.1
Konac, E.2
Eroglu, M.3
Guneri, C.4
Biri, H.5
Ekmekci, A.6
-
11
-
-
38449109288
-
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer
-
Fukuda H., Tsuchiya N., Narita S., et al. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer. Oncol Rep 18 (2007) 1155-1163
-
(2007)
Oncol Rep
, vol.18
, pp. 1155-1163
-
-
Fukuda, H.1
Tsuchiya, N.2
Narita, S.3
-
12
-
-
39449093139
-
The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases
-
Langsenlehner T., Langsenlehner U., Renner W., et al. The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases. Prostate 68 (2008) 264-268
-
(2008)
Prostate
, vol.68
, pp. 264-268
-
-
Langsenlehner, T.1
Langsenlehner, U.2
Renner, W.3
-
13
-
-
33846581376
-
Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study
-
Eder T., Mayer R., Langsenlehner U., et al. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study. Eur J Cancer 43 (2007) 472-475
-
(2007)
Eur J Cancer
, vol.43
, pp. 472-475
-
-
Eder, T.1
Mayer, R.2
Langsenlehner, U.3
-
14
-
-
0036316846
-
A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes
-
Awata T., Inoue K., Kurihara S., et al. A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51 (2002) 1635-1639
-
(2002)
Diabetes
, vol.51
, pp. 1635-1639
-
-
Awata, T.1
Inoue, K.2
Kurihara, S.3
-
15
-
-
0034509524
-
A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels
-
Renner W., Kotschan S., Hoffmann C., Obermayer-Pietsch B., and Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 37 (2000) 443-448
-
(2000)
J Vasc Res
, vol.37
, pp. 443-448
-
-
Renner, W.1
Kotschan, S.2
Hoffmann, C.3
Obermayer-Pietsch, B.4
Pilger, E.5
-
16
-
-
0033400238
-
Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene
-
Brogan I.J., Khan N., Isaac K., Hutchinson J.A., Pravica V., and Hutchinson I.V. Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 60 (1999) 1245-1249
-
(1999)
Hum Immunol
, vol.60
, pp. 1245-1249
-
-
Brogan, I.J.1
Khan, N.2
Isaac, K.3
Hutchinson, J.A.4
Pravica, V.5
Hutchinson, I.V.6
-
17
-
-
0033865580
-
Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production
-
Watson C.J., Webb N.J., Bottomley M.J., and Brenchley P.E. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12 (2000) 1232-1235
-
(2000)
Cytokine
, vol.12
, pp. 1232-1235
-
-
Watson, C.J.1
Webb, N.J.2
Bottomley, M.J.3
Brenchley, P.E.4
-
18
-
-
0035071957
-
A new statistical method for haplotype reconstruction from population data
-
Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68 (2001) 978-989
-
(2001)
Am J Hum Genet
, vol.68
, pp. 978-989
-
-
Stephens, M.1
Smith, N.J.2
Donnelly, P.3
-
20
-
-
0036065699
-
SNP judgments and freedom of association
-
Hegele R.A. SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol 22 (2002) 1058-1061
-
(2002)
Arterioscler Thromb Vasc Biol
, vol.22
, pp. 1058-1061
-
-
Hegele, R.A.1
-
21
-
-
33746808629
-
Role of vascular endothelial growth factor in prostate cancer
-
Delongchamps N.B., Peyromaure M., and Dinh-Xuan A.T. Role of vascular endothelial growth factor in prostate cancer. Urology 68 (2006) 244-248
-
(2006)
Urology
, vol.68
, pp. 244-248
-
-
Delongchamps, N.B.1
Peyromaure, M.2
Dinh-Xuan, A.T.3
-
22
-
-
33845267785
-
Heritability for plasma VEGF concentration in the Stanislas family study
-
Berrahmoune H., Herbeth B., Lamont J.V., Masson C., Fitzgerald P.S., and Visvikis-Siest S. Heritability for plasma VEGF concentration in the Stanislas family study. Ann Hum Genet 71 (2007) 54-63
-
(2007)
Ann Hum Genet
, vol.71
, pp. 54-63
-
-
Berrahmoune, H.1
Herbeth, B.2
Lamont, J.V.3
Masson, C.4
Fitzgerald, P.S.5
Visvikis-Siest, S.6
-
23
-
-
33748458449
-
The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease
-
Ferrante M., Pierik M., Henckaerts L., et al. The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflamm Bowel Dis 12 (2006) 870-878
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 870-878
-
-
Ferrante, M.1
Pierik, M.2
Henckaerts, L.3
-
24
-
-
50649087219
-
-
Nam RK, Zhang WW, Loblaw DA, et al. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer. Prostate Cancer Prostatic Dis 2007. doi:10.1038/sj.pcan.4501010.
-
Nam RK, Zhang WW, Loblaw DA, et al. A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer. Prostate Cancer Prostatic Dis 2007. doi:10.1038/sj.pcan.4501010.
-
-
-
-
25
-
-
35748974205
-
A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study
-
Murabito J.M., Rosenberg C.L., Finger D., et al. A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study. BMC Med Genet 8 (2007) S6
-
(2007)
BMC Med Genet
, vol.8
-
-
Murabito, J.M.1
Rosenberg, C.L.2
Finger, D.3
-
26
-
-
38449103390
-
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP
-
Duggan D., Zheng S.L., Knowlton M., et al. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst 99 (2007) 1836-1844
-
(2007)
J Natl Cancer Inst
, vol.99
, pp. 1836-1844
-
-
Duggan, D.1
Zheng, S.L.2
Knowlton, M.3
-
27
-
-
33745169697
-
A common variant associated with prostate cancer in European and African populations
-
Amundadottir L.T., Sulem P., Gudmundsson J., et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 38 (2006) 652-658
-
(2006)
Nat Genet
, vol.38
, pp. 652-658
-
-
Amundadottir, L.T.1
Sulem, P.2
Gudmundsson, J.3
-
28
-
-
38749105099
-
Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer
-
Gustavsson H., Jennbacken K., Welén K., and Damber J.E. Altered expression of genes regulating angiogenesis in experimental androgen-independent prostate cancer. Prostate 68 (2008) 161-170
-
(2008)
Prostate
, vol.68
, pp. 161-170
-
-
Gustavsson, H.1
Jennbacken, K.2
Welén, K.3
Damber, J.E.4
-
29
-
-
34548770084
-
Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer
-
Li H., Bubley G.J., Balk S.P., et al. Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. Prostate 67 (2007) 1354-1361
-
(2007)
Prostate
, vol.67
, pp. 1354-1361
-
-
Li, H.1
Bubley, G.J.2
Balk, S.P.3
-
30
-
-
31944448886
-
A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network
-
Menendez D., Krysiak O., Inga A., Krysiak B., Resnick M.A., and Schonfelder G. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Proc Natl Acad Sci USA 103 (2006) 1406-1411
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 1406-1411
-
-
Menendez, D.1
Krysiak, O.2
Inga, A.3
Krysiak, B.4
Resnick, M.A.5
Schonfelder, G.6
|